Breaking News
Pathway to the stars
The Prostate Cancer Test Dilemma
The Separation of Righteousness and Politics
Russian strike knocks out power in Kyiv FRANCE 24 English
Top Tech News
How underwater 3D printing could soon transform maritime construction
Smart soldering iron packs a camera to show you what you're doing
Look, no hands: Flying umbrella follows user through the rain
Critical Linux Warning: 800,000 Devices Are EXPOSED
'Brave New World': IVF Company's Eugenics Tool Lets Couples Pick 'Best' Baby, Di
The smartphone just fired a warning shot at the camera industry.
A revolutionary breakthrough in dental science is changing how we fight tooth decay
Docan Energy "Panda": 32kWh for $2,530!
Rugged phone with multi-day battery life doubles as a 1080p projector
4 Sisters Invent Electric Tractor with Mom and Dad and it's Selling in 5 Countries
Tumor-Destroying Sound Waves Treatment Coming to a Hospital Near You For Liver Cancer
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.